When BlueSemi Technologies approached T-Hub, they had a bold vision — to build India’s first non-invasive health tech device that could monitor blood vitals without a single drop of blood. What they lacked was access to strategic mentors, investor connects, and real-world testing opportunities. Through T-Hub’s Lab32 accelerator, BlueSemi refined its product, redefined its GTM strategy, and gained exposure at global platforms. The startup secured multiple rounds of funding and launched its flagship product, eyva, revolutionizing preventive health monitoring in India. T-Hub’s support wasn’t just mentorship — it was a full-stack ecosystem built to scale innovation.